Xeris Pharmaceuticals | XERS - 销售毛利

金融业

USD

USD 383.53M

现金及等价物

USD 111.04M

USD 13.66M

USD 240.31M

USD 109.57M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.05

股本和储备

USD 13.69M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 220.34M

USD 786.5M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 85.81M

销售和管理费用

USD 42.64M

USD 68.67M

贸易债权人

USD 3.08M

应收帐款人

USD 51.05M

	销售毛利	更改		日
Celltrion	KRW 626.11B		81.75B	2025-09
Cspc Pharmaceutical	CNY 4.34B		333.68M	2025-09
Deva Holding AS	TRY 1.32B		235.77M	2023-09
Dianthus Therapeutics	USD 284K		112K	2025-12
Divis Laboratories Ltd	INR 16.59B		2.05B	2025-12
Eli Lilly	USD 14.59B		1.48B	2025-09
Kangmei Pharma	CNY 270.29M		20.26M	2025-09
Knight Therapeutics	CAD 64.72M		8.91M	2025-12
Laboratorios Farma	EUR 105.28M		177.08M	2025-06
Medical Developments International	AUD 7.35M		7.37M	2025-06
Nektar Therapeutics	USD 13.75M		650K	2024-06
Neuren Pharmaceuticals	AUD 6.69M		6.37M	2025-06
Organigram Holdings	CAD 23.32M		8.52M	2025-12
Pacira	USD 142.25M		11.34M	2025-12
Perrigo	USD 362.2M		14.9M	2025-12
Pharma Mar	EUR 86.7M		53.34M	2025-12
Qiagen NV	USD 325.27M		19.53M	2025-12
Sartorius	EUR 393.2M		23M	2025-09
Sino Biopharmaceutical	CNY 10.5B		2.53B	2024-12
Supernus Pharmaceuticals	USD 164.04M		15.23M	2025-12
Tilray	USD 57.47M		10.16M	2025-06
Zealand Pharma A/S	68.91M		19.35M	2025-12
Zz Pientze Pharmaceu	CNY 296.13M		1.1B	2025-06